newsfilter
← Latest News
GlobeNewswire·

Myriad Genetics to Release Second Quarter 2026 Financial Results on July 30, 2026

SALT LAKE CITY, July 23, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ:MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its second quarter 2026 earnings conference call at